Bibliographic Details
| Title: |
Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic. |
| Authors: |
Becker, Zoey (AUTHOR) |
| Source: |
FierceBiotech. 12/4/2024, pN.PAG-N.PAG. 1p. |
| Subject Terms: |
*Venture capital, Obesity, Drugs, Teams |
| Abstract: |
Antag Therapeutics' founding team includes Jens Holst, M.D., who received worldwide acclaim for helping discover GLP-1 in the 1980s. [ABSTRACT FROM AUTHOR] |
|
Copyright of FierceBiotech is the property of Questex Media Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Business Source Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
